About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

1 1 (January 11, 2021)

handle is hein.crs/govebnk0001 and id is 1 raw text is: Congressional *aResearch Service Funding for COVID-19 Vaccines: An Overview Updated January 11, 2021 The U.S. Food and Drug Administration (FDA) has authorized for emergency use Coronavirus Disease 2019 (COVID-19) vaccines sponsored by Pfizer/BioNTech and Moderna. Several other COVID-19 vaccines are currently in clinical trials; additional vaccines may become available within months. Operation Warp Speed (OWS)-the COVID-19 medical countermeasure initiative led by the Department of Health and Human Services (HHS) and the Department of Defense (DOD)-has contracted with manufacturers to purchase hundreds of millions of doses (including Pfizer/BioNTech and Moderna's vaccines) and related supplies. OWS is also planning and implementing a nationwide vaccine program. OWS has thus far been financed largely by emergency funding provided in the coronavirus supplemental appropriations acts. In the FY2020 laws, not much was appropriated specifically for COVID-19 vaccine- related efforts; instead, several accounts have funding available for relevant activities. In FY2021, Division M of P.L. 116-260 includes emergency appropriations directed for vaccine-specific activities. Much of the HHS supplemental funding is available for multiple years or until expended. In addition, HHS transfer authorities in the laws allow for transfers between funds in certain HHS accounts. This Insight provides overviews of supplemental appropriations for selected vaccine-related activities and available information on allocations and obligations. It does not address health care financing issues related to vaccine administration or regular appropriations. Vaccine Research and Development, Manufacturing, and Purchase COVID-19 vaccine research and development (R&D), manufacturing, and purchasing efforts are largely supported by OWS, a collaboration among several federal agencies, including the National Institutes of Health (NIH), the Biomedical Advanced Research and Development Authority (BARDA), DOD, and others. Some vaccine R&D is supported by NIH, BARDA, and DOD separately from the OWS efforts. Appropriations FY2020. In two of the four FY2020 coronavirus supplemental appropriations acts (P.L. 116-123 and P.L. 116-136), funding was made available for vaccine-related efforts to accounts at NIH, DOD, and the Public Health and Social Services Emergency Fund (PHSSEF). (PHSSEF, the parent account for BARDA, is an account for the HHS Secretary that funds additional emergency preparedness and response Congressional Research Service https://crsreports.congress.gov IN11556 CRS INSIGHT Prepared for Members and Committees of Congress

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Purchase Access

Contact us for annual subscription options:

Contact Us

Already a HeinOnline Subscriber?

Log In

profiles profiles most